The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification
The campaign aims to bring back focus on leprosy case detection, treatment and rehabilitation; especially in the context of neglect brought in by Covid-19 pandemic
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
It recommends using the vaccine to prevent the spread of the disease
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)